These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38695869)

  • 1. Multiplexed Imaging Mass Cytometry Analysis Characterizes the Vascular Niche in Pancreatic Cancer.
    Sussman JH; Kim N; Kemp SB; Traum D; Katsuda T; Kahn BM; Xu J; Kim IK; Eskandarian C; Delman D; Beatty GL; Kaestner KH; Simpson AL; Stanger BZ
    Cancer Res; 2024 Jul; 84(14):2364-2376. PubMed ID: 38695869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells.
    Choi JI; Jang SI; Hong J; Kim CH; Kwon SS; Park JS; Lim JB
    Cancer Lett; 2021 Feb; 498():42-53. PubMed ID: 33188841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
    Lin W; Noel P; Borazanci EH; Lee J; Amini A; Han IW; Heo JS; Jameson GS; Fraser C; Steinbach M; Woo Y; Fong Y; Cridebring D; Von Hoff DD; Park JO; Han H
    Genome Med; 2020 Sep; 12(1):80. PubMed ID: 32988401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
    Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
    Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the spatial distribution of extracellular adenosine revealed a myeloid-dependent immunosuppressive microenvironment in pancreatic ductal adenocarcinoma.
    Graziano V; Dannhorn A; Hulme H; Williamson K; Buckley H; Karim SA; Wilson M; Lee SY; Kaistha BP; Islam S; Thaventhiran JED; Richards FM; Goodwin R; Brais R; Morton JP; Dovedi SJ; Schuller AG; Eyles J; Jodrell DI
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37553182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer.
    Erreni M; Fumagalli MR; Zanini D; Candiello E; Tiberi G; Parente R; D'Anna R; Magrini E; Marchesi F; Cappello P; Doni A
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties.
    Rubiano A; Delitto D; Han S; Gerber M; Galitz C; Trevino J; Thomas RM; Hughes SJ; Simmons CS
    Acta Biomater; 2018 Feb; 67():331-340. PubMed ID: 29191507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome.
    Biondani G; Zeeberg K; Greco MR; Cannone S; Dando I; Dalla Pozza E; Mastrodonato M; Forciniti S; Casavola V; Palmieri M; Reshkin SJ; Cardone RA
    FEBS J; 2018 Jun; 285(11):2104-2124. PubMed ID: 29660229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
    Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
    Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Spatial Profiling of Immune Populations in Pancreatic Ductal Adenocarcinoma Reveals Tumor Microenvironment Heterogeneity and Prognostic Biomarkers.
    Mi H; Sivagnanam S; Betts CB; Liudahl SM; Jaffee EM; Coussens LM; Popel AS
    Cancer Res; 2022 Dec; 82(23):4359-4372. PubMed ID: 36112643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.
    Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
    Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma and their clinical implications.
    Park JK; Jeong HO; Kim H; Choi JH; Lee EM; Kim S; Jang J; Choi DW; Lee SH; Kim KM; Jang KT; Lee KH; Lee KT; Lee MW; Lee JK; Lee S
    Mol Cancer; 2024 May; 23(1):87. PubMed ID: 38702773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow-derived proangiogenic cells in pancreatic cancer.
    Mizukami Y
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():23-6. PubMed ID: 22320912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma.
    Esposito I; Menicagli M; Funel N; Bergmann F; Boggi U; Mosca F; Bevilacqua G; Campani D
    J Clin Pathol; 2004 Jun; 57(6):630-6. PubMed ID: 15166270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning analyses of highly-multiplexed immunofluorescence identifies distinct tumor and stromal cell populations in primary pancreatic tumors.
    Vance K; Alitinok A; Winfree S; Jensen-Smith H; Swanson BJ; Grandgenett PM; Klute KA; Crichton DJ; Hollingsworth MA
    Cancer Biomark; 2022; 33(2):219-235. PubMed ID: 35213363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer.
    Ligorio M; Sil S; Malagon-Lopez J; Nieman LT; Misale S; Di Pilato M; Ebright RY; Karabacak MN; Kulkarni AS; Liu A; Vincent Jordan N; Franses JW; Philipp J; Kreuzer J; Desai N; Arora KS; Rajurkar M; Horwitz E; Neyaz A; Tai E; Magnus NKC; Vo KD; Yashaswini CN; Marangoni F; Boukhali M; Fatherree JP; Damon LJ; Xega K; Desai R; Choz M; Bersani F; Langenbucher A; Thapar V; Morris R; Wellner UF; Schilling O; Lawrence MS; Liss AS; Rivera MN; Deshpande V; Benes CH; Maheswaran S; Haber DA; Fernandez-Del-Castillo C; Ferrone CR; Haas W; Aryee MJ; Ting DT
    Cell; 2019 Jun; 178(1):160-175.e27. PubMed ID: 31155233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.
    Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
    Eur J Surg Oncol; 2014 Oct; 40(10):1331-7. PubMed ID: 24480377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma.
    Molejon MI; Tellechea JI; Loncle C; Gayet O; Gilabert M; Duconseil P; Lopez-Millan MB; Moutardier V; Gasmi M; Garcia S; Turrini O; Ouaissi M; Poizat F; Dusetti N; Iovanna J
    Oncotarget; 2015 Apr; 6(10):7408-23. PubMed ID: 25797268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
    Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
    Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.